Ensuring R&D Success through Transformative Lab Operations

Implement Next Generation Asset Management, Facility Design, Supply Chain & Sustainability, to Free Up Capital for Reinvestment & Provide a
Lab Environment Primed for Innovation

NOVEMBER 1-3, 2022 | BOSTON, MA

Pharma R&D return on investment has risen to its highest levels since 2014, there’s never been a more impactful time to translate savings in capital spend into results for patients in need. The 5th LAFM Summit will return to unite lab operations, asset and facility managers in their quest to support stakeholders, manage reactive business continuity whilst providing a platform for sustainable & ambitious organizational growth.

As the only peer led community for R&D operations leaders, from large pharma to start-ups, meet your new network this November and level up your career in lab operations, facility and asset management.

New for 2022 the 5th LAFM summit will host three tracks of content to dive down into asset management and maintenance in large pharma, facility design in expanding organizations, and end-to-end operations in early-stage biotech.

Leverage next generation technologies, overcome supply chain challenges and find inspiration to make a real impact in your organization, no matter your headcount or resources.

A Unique Opportunity to Join 300+ Members of the Pharma & Biotech Community Including...

LAFM - Sponsor logos

40+ Expert Industry Speakers:

Large Pharma

Charles Bruseo

Director, Research Strategy & Operations

Bristol Myers Squibb

JD Fier

Head of MA Bio Ops Reliability Engineering

Takeda Pharmaceutical Co. Ltd.

Jessie Dow

Lab Operations Lead

Pfizer

Jill DeGreen

Senior Manager - Operations

Novo Nordisk

Marloes Miller

Senior Director, R&D Lab Operations

AstraZeneca

Partha Krishnan

Deputy Director - Health, Safety & Environment

Sanofi

Richard Snell

Scientific Services Director

GSK

Exciting Biotech

Amanda Allen

Executive Director, Facilities & Operations

Odyssey Therapeutics

Erika Whyte

Senior Director, Operations

Totus Medicines

Mikhael Danan

Director R&D, Clinical IT

Affinivax

Sandy Morales

Director, Facilities & EH&S

Concert Pharmaceuticals

Conference Chairs

Demet Aybar

Director of Facilities & Lab Operations

Strand Therapeutics

Katya Henderson

Vice President, Operations

ENSEM Therapeutics

Kim Dougherty

Director, Laboratory Operations

Atalanta Therapeutics

Steven Driver

Principal Engineer and Energy Program Mananger

Sanofi

What’s New for 2022?

asset

Refocused: Asset Management Track

The AM track hones in on the cutting edge asset management programs at large pharma, uncovering next generation asset monitoring, utilization, maintenance and reliability innovations across the full asset lifecycle

design

Refocused: Facility Design & Digital Facilities Track

With space as the hottest commodity in biopharma, this track highlights the most recent facility designs to maximize space and workflow efficiency, sustainability and digital tools

biotech

New: Early-Stage Biotech Track

This brand-new track for 2022 covers a comprehensive view of lab operations in start-up & SME biotech, the flexible and adaptable solutions to working in a fastgrowing company, and the many hats a lab operations professional has to juggle in the start up and SME biotech world!